Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Not applicableStudy completedNCT03665766
What this trial is testing

Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation

Who this might be right for
Liver Transplantation
Ain Shams University 126
Post-approval studies (Phase 4)UnknownNCT03402165
What this trial is testing

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Sherief Abd-Elsalam 1,200
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Testing effectiveness (Phase 2)Study completedNCT00035945
What this trial is testing

ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections

Who this might be right for
Hepatitis C, Chronic
Ionis Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Not applicableWithdrawnNCT00165919
What this trial is testing

Immune Response to Hepatitis C Virus

Who this might be right for
Hepatitis CHIV Infections
Emory University
Testing effectiveness (Phase 2)Study completedNCT00987337
What this trial is testing

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Who this might be right for
HepatitisHepatitis C
Pfizer 288
Post-approval studies (Phase 4)Study completedNCT03537196
What this trial is testing

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)

Who this might be right for
Hepatitis CDrug UseViral Hepatitis C
ANRS, Emerging Infectious Diseases 979
Not applicableUnknownNCT03110055
What this trial is testing

The Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC.

Who this might be right for
HCV, HCC
Tel-Aviv Sourasky Medical Center 20
Post-approval studies (Phase 4)Study completedNCT00207363
What this trial is testing

Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC

Who this might be right for
Hepatitis C
Brooke Army Medical Center 610
Not applicableStudy completedNCT02402699
What this trial is testing

Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan

Who this might be right for
Advanced MelanomaHepatitis BHepatitis C
Bristol-Myers Squibb 3
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Post-approval studies (Phase 4)Study completedNCT03949764
What this trial is testing

The Kentucky Viral Hepatitis Treatment Study

Who this might be right for
Hepatitis COpioid-Related DisordersInjection Drug Use
Jennifer Havens 374
Testing effectiveness (Phase 2)Study completedNCT00389298
What this trial is testing

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 36
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Post-approval studies (Phase 4)Study completedNCT02064049
What this trial is testing

Surveillance and Treatment of Prisoners With Hepatitis C

Who this might be right for
Hepatitis C
Kirby Institute 3,692
Not applicableWithdrawnNCT03208322
What this trial is testing

Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02201901
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 268
Early research (Phase 1)Study completedNCT01290965
What this trial is testing

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Scynexis, Inc. 57
Early research (Phase 1)Study completedNCT02103569
What this trial is testing

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation